Shin W. Kang
InvestorChief Scientific Officer at HEALTHCARE ROYALTY PARTNERS
Find your path to Shin
34 people in our graph share verified history with Shin — schools, employers, funds. One of them is your warm intro.
About
Shin W. Kang serves as Chief Scientific Officer and Head of Research at HCRx, where he leads research efforts and sourcing tied to universities, research institutions, and inventors, having joined in 2015. Before HCRx, he was a vice president of equity research covering biotechnology at Wells Fargo Securities and previously handled technology, intellectual property, and business development at the Mount Sinai School of Medicine. He holds a PhD in Biological Chemistry/Immunology from UCLA, an MBA from Columbia Business School, and a BS from UC Davis, and completed a postdoctoral fellowship at Genentech.
Invests in
Biotech
Colleagues at HEALTHCARE ROYALTY PARTNERS
Frequently asked questions
- Who is Shin W. Kang?
- Shin W. Kang serves as Chief Scientific Officer and Head of Research at HCRx, where he leads research efforts and sourcing tied to universities, research institutions, and inventors, having joined in 2015. Before HCRx, he was a vice president of equity research covering biotechnology at Wells Fargo Securities and previously handled technology, intellectual property, and business development at the Mount Sinai School of Medicine. He holds a PhD in Biological Chemistry/Immunology from UCLA, an MBA from Columbia Business School, and a BS from UC Davis, and completed a postdoctoral fellowship at Genentech.
- Where does Shin W. Kang work?
- Shin W. Kang is Chief Scientific Officer at HEALTHCARE ROYALTY PARTNERS.
- What does Shin W. Kang invest in?
- Shin W. Kang invests in Biotech.